Latest / Becker’s Healthcare Podcast / Jeffrey Singerman, Administrator and COO, Manhattan Endoscopy Center

Transcript

Jeffrey Singerman, Administrator and COO, Manhattan Endoscopy Center · Becker’s Healthcare Podcast

• 0:00
  Looking for a solution that helps alleviate administrative
• 0:03
  tasks for your staff and also helps your
• 0:05
  patients cover their out of pocket health care
• 0:07
  expenses?
• 0:08
  Find what you're looking for from CareCredit because
• 0:11
  CareCredit is a credit card and more. It's
• 0:13
  a helping hand for staff and a flexible
• 0:16
  payment solution for patients. For over thirty years,
• 0:19
  CareCredit, a Synchrony solution, has offered patients a
• 0:22
  credit card with promotional financing options to get
• 0:25
  the care they want while helping staff do
• 0:27
  what they do best, provide care. To learn
• 0:30
  more, visit carecredit.com
• 0:32
  forward slash beckers podcast.
• 0:35
  This is Gracelyn Keller with the Becker's Healthcare
• 0:37
  Podcast, and we are recording live at the
• 0:39
  thirty first annual business and operations of ASCs.
• 0:42
  I'm currently sitting down with Jeffrey Singerman, who
• 0:45
  is the administrator and COO at Manhattan Endoscopy
• 0:48
  Center. Jeffrey, thanks for being here. To kick
• 0:51
  us off, can you share a little bit
• 0:52
  about yourself and your work in the ASC
• 0:54
  space? Sure. Good morning. So as you said,
• 0:56
  my name is Jeff Singerman. I am the
• 0:57
  chief operating officer slash administrator for Manhattan Endoscopy.
• 1:01
  We are a single specialty,
• 1:05
  nonhospital affiliated,
• 1:07
  ASC
• 1:08
  located in Midtown Manhattan.
• 1:11
  We are GI specific. We have seven procedure
• 1:14
  rooms and should probably end the year with
• 1:17
  about 10,000 patients coming through the door.
• 1:20
  Alright.
• 1:21
  Well, thanks for being here. And let's start
• 1:22
  our conversation with the ASC market. Because in
• 1:25
  The US, this is projected to reach $60,800,000,000
• 1:28
  by 2030,
• 1:30
  and it continues to experience strong year over
• 1:32
  year growth. From your perspective, what are the
• 1:35
  most significant trends in market forces driving this
• 1:37
  expansion, and how should ASC leaders be preparing
• 1:40
  today?
• 1:41
  So I think part of this trend is
• 1:43
  contributed
• 1:45
  to the
• 1:46
  cost base between the hospital, the hospital OPD,
• 1:50
  and the ASC.
• 1:52
  The cost base is much lower
• 1:54
  at in the within the ASC environment.
• 1:57
  And our outcomes,
• 1:59
  I'm happy to say, are probably as good,
• 2:01
  if not better, than what goes on in
• 2:03
  the hospital. And then the second part that
• 2:06
  I think is contributing to this
• 2:08
  is
• 2:09
  that we can pivot
• 2:11
  from a technological
• 2:12
  standpoint
• 2:13
  much quicker
• 2:15
  than the larger health systems that have to
• 2:17
  go through layers and layers of bureaucracy
• 2:21
  to obtain what we can do in almost
• 2:23
  a instantaneous
• 2:24
  decision.
• 2:26
  From a administrator's
• 2:27
  standpoint or a COO standpoint,
• 2:30
  I believe that you need to be flexible,
• 2:33
  open minded, and evaluate
• 2:35
  what your ROI is gonna be on any
• 2:37
  investment that you're gonna make as this trend
• 2:39
  continues.
• 2:41
  Absolutely.
• 2:42
  And shifting gears slightly
• 2:44
  from AI and robotic surgeries to advanced DHR
• 2:46
  systems, technology does remain a make or break
• 2:49
  factor and a critical driver of ASC operations
• 2:51
  at scale.
• 2:52
  So how do you see deeper deeper tech
• 2:54
  integration shaping the way ASCs deliver care and
• 2:56
  manage their business over the next few years?
• 2:59
  So I kinda divide this into
• 3:02
  two different venues. I think one is a
• 3:04
  clinical venue and one is an administrative venue.
• 3:07
  So from a clinical standpoint
• 3:09
  and we've gone through
• 3:11
  two, if not three tests of AI,
• 3:14
  and its current iteration,
• 3:16
  it really has not helped in the GI
• 3:18
  environment.
• 3:19
  I think when we look out in 2030,
• 3:22
  I think where we'll probably see the most
• 3:24
  advances
• 3:25
  will be in polyp detection
• 3:28
  and possibly being able to look at when
• 3:30
  a when a gastroenterologist
• 3:32
  is doing histology,
• 3:34
  in an area where their mucosal changes,
• 3:37
  that they conceivably
• 3:38
  determine if this is cancers or not before
• 3:41
  it's ever removed from the body.
• 3:43
  But where I really see
• 3:44
  in 2030, and if not sooner,
• 3:47
  the impacts on the administrative side, which would
• 3:50
  ultimately, I believe, reduce staffing
• 3:53
  and
• 3:54
  help
• 3:55
  in the area of documentation
• 3:57
  from a physician standpoint as well
• 4:00
  that they can meet the criteria
• 4:02
  that the insurance companies are putting up there
• 4:06
  to
• 4:07
  inhibit reimbursement
• 4:09
  or look for excuses to deny claims.
• 4:12
  And following up to that, is there any
• 4:14
  specific technology or innovation that stands out to
• 4:17
  you as especially transformative?
• 4:19
  Probably gonna be on the EMR side.
• 4:22
  And I I see beta testing now going
• 4:25
  on in
• 4:27
  voice dictation for procedure notes,
• 4:30
  much different than what we saw in radiology
• 4:32
  in the last five to ten years.
• 4:34
  And I'm also starting to see it in
• 4:36
  working with one company and helping to develop
• 4:39
  some of it in the procedure documentation area.
• 4:41
  And I think those may have the biggest
• 4:42
  impact in the next eighteen to twenty four
• 4:44
  months. 100%.
• 4:46
  And with 60% of health systems considering ASC
• 4:49
  joint ventures
• 4:50
  and many ASCs already partnering with systems in
• 4:53
  their communities, what opportunities do you see for
• 4:55
  collaboration whether with other providers or vendors to
• 4:58
  strengthen patient care and operational efficiency?
• 5:00
  Great question.
• 5:02
  And I think where I see the it's
• 5:04
  a couple places where I'm gonna there will
• 5:06
  be a large impact. One, I think it's
• 5:08
  gonna make it easier, especially with hot hospital
• 5:11
  partnerships,
• 5:13
  to recruit
• 5:14
  and do succession planning. So if you think
• 5:17
  about it now, the average fellow coming out
• 5:19
  of,
• 5:21
  fellowship is probably somewhere about a half $1,000,000
• 5:23
  in debt
• 5:25
  and has to make a decision, do I
• 5:27
  go to an ASC environment or a hospital
• 5:29
  environment? And right now, the hospital environment is
• 5:31
  more
• 5:32
  conducive
• 5:34
  for salary stabilization.
• 5:36
  If there's that partnership there,
• 5:39
  the hospital
• 5:41
  can direct or feed the ASC environment
• 5:44
  the
• 5:45
  physicians necessary to maintain as close to a
• 5:48
  100% occupancy as possible.
• 5:50
  The second area, and there's a nationwide shortage
• 5:53
  in anesthesia and nursing,
• 5:55
  they'll help that as well in being able
• 5:57
  to move staff around to
• 5:59
  substitute in where there are callouts and of
• 6:02
  that nature.
• 6:04
  And as we wrap up our conversation today,
• 6:06
  is there anything that we didn't touch on
• 6:08
  or any final thoughts you'd like to share
• 6:09
  on the podcast?
• 6:11
  Yeah. I think from an administrative standpoint, I
• 6:13
  think any administrator needs to be flexible,
• 6:16
  and they need to do their homework. They
• 6:17
  need to do their due diligence to ensure
• 6:20
  that whatever investments they're making are gonna be
• 6:23
  in the best interest for the ASC.
• 6:25
  Absolutely. Well, Jeff, thanks so much for being
• 6:27
  here today on the Becker's Healthcare podcast to
• 6:29
  share these thoughts and insights. Again, we are
• 6:31
  recording live at the thirty first annual business
• 6:33
  and operations of ASCs. Thank you. My pleasure.